Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) will report first quarter 2026 financial results after market close on Monday, May 4, 2026.
A management conference call will begin at 5:00 p.m. Eastern Time the same day and will be webcast via the company's Investor Relations page. Registration is required to ask questions; registrants receive dial-in details and a unique access code. The company recommends registering at least 10 minutes before the call. A replay will be available approximately two hours after the event and archived on the Investor Relations site for two weeks.
Positive
- None.
Negative
- None.
News Market Reaction – INSP
In the Apr 6 session, INSP declined 1.55%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 07 | Earnings date set | Neutral | +1.9% | Announced date and webcast details for Q4 and FY 2025 results. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings date scheduling news saw a modest positive reaction of 1.87%, suggesting investors have previously responded mildly favorably to similar announcements.
Recent history shows INSP communicating regularly with investors through conference presentations, earnings releases, and earnings date announcements. A prior earnings date notice on Jan 7, 2026 coincided with a 1.87% gain. Subsequent earnings reports highlighted strong 2025 revenue of $912.0M and guidance for continued growth in 2026. Today’s Q1 2026 earnings date fits this pattern of consistent disclosure and scheduled calls.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2026 after the close of trading on Monday, May 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q1 2026 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.
If you plan to ask a question, please use the following link: Inspire's Q1 2026 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.
Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
